Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

Analyst Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non ...

Internuclear ophthalmoplegia is common in MS and results from damage to interneurons travelling from the cranial nerve (CN) VI nucleus in the pons to the contralateral medial rectus subnucleus of ...

Good afternoon, ladies and gentlemen, and welcome to the INOVIO First Quarter 2024 Financial Results Conference Call. At this time all lines are in a listen-only mode. Following the presentation ...

Inovalis REIT has listed on the Toronto Stock Exchange (TSX) under the ticker INO-UN. A total of 19,804 shares was traded during the last trading day, with total trades of 30, with an average ...

Inovalis Real Estate Investment Trust is a Canada based open-ended real estate investment trust. The REIT Properties consist of office properties that are used for the rental of office space ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

Cash Runway: Extended into the third quarter of 2025, including net proceeds from recent capital raise. Warning! GuruFocus has detected 4 Warning Signs with INO. Release Date: May 13, 2024 ...

NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ...